HIV gp120s and Their Role in Mucosal Transmission
Author Information
Author(s): Nawaz Fatima, Cicala Claudia, Van Ryk Donald, Block Katharine E., Jelicic Katija, McNally Jonathan P., Ogundare Olajumoke, Pascuccio Massimiliano, Patel Nikita, Wei Danlan, Fauci Anthony S., Arthos James
Primary Institution: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
Hypothesis
The genotype of early-transmitting HIV gp120s promotes α4β7-reactivity, revealing α4β7+/CD4+ T cells as key targets in mucosal transmission.
Conclusion
Early-transmitting HIV gp120s exhibit increased α4β7-reactivity, which may enhance their transmission fitness.
Supporting Evidence
- Early-transmitting HIV gp120s have fewer N-linked glycosylation sites compared to chronic variants.
- Increased α4β7-reactivity is linked to specific genetic features of early-transmitting gp120s.
- Understanding the structural features of early-transmitting gp120s may aid in vaccine design.
Takeaway
HIV can be more easily spread when it targets specific immune cells in the gut, and some early forms of the virus are better at doing this.
Methodology
The study used flow-cytometry based assays to analyze the binding of HIV gp120s to α4β7+/CD4+ T cells.
Limitations
The study only analyzed a limited number of early-transmitting gp120s, which may not represent all variants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website